XML 34 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
12 Months Ended
Dec. 31, 2013
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The components of income (loss) from continuing operations before income taxes consist of the following (in thousands):
 
Year ended December 31,
 
2013
 
2012
 
2011
Loss before income taxes:
 
 
 
 
 
United States
$
(21,076
)
 
$
(49,337
)
 
$
(13,144
)
Foreign
409

 
1,609

 
1,906

 
$
(20,667
)
 
$
(47,728
)
 
$
(11,238
)


The provision (benefit) for income taxes from continuing operations consists of the following (in thousands):
 
Year ended December 31,
 
2013
 
2012
 
2011
Provision (benefit) for income taxes:
 
 
 
 
 
Current:
 
 
 
 
 
Federal
$
14

 
$
14

 
$
14

State
150

 
105

 
183

Foreign
1,696

 
1,465

 
1,212

Total current
1,860

 
1,584

 
1,409

Deferred:
 
 
 
 
 
Federal
(1,911
)
 
(12,441
)
 
(140
)
State
(103
)
 
(1,680
)
 
696

Foreign
(1,081
)
 
607

 
56

Change in valuation allowance
2,687

 
14,371

 
(556
)
Total deferred
(408
)
 
857

 
56

Total
$
1,452

 
$
2,441

 
$
1,465



A reconciliation of the Company's effective tax rate for continuing operations to the statutory federal rate is as follows:
 
Year ended December 31,
 
2013
 
2012
 
2011
U.S. statutory income tax rate
(35.0
)%
 
(35.0
)%
 
(35.0
)%
State income taxes, net of federal benefit
0.4

 
(3.6
)
 
6.0

Foreign income taxes
1.3

 
3.2

 
5.3

Capital loss expiration
24.0

 
—

 
—

Foreign deemed dividends
1.8

 
2.1

 
9.3

Stock-based compensation
7.6

 
3.4

 
14.9

Tax credits
(6.1
)
 
(0.7
)
 
3.2

Uncertain tax positions
—

 
—

 
0.1

Deferred cost of goods sold elimination
—

 
(1.2
)
 
5.0

Valuation allowance
9.9

 
35.5

 
2.0

Goodwill amortization
3.3

 
0.5

 
—

Other, net
(0.2
)
 
0.9

 
2.2

Effective income tax rate
7.0
 %
 
5.1
 %
 
13.0
 %



The following is a summary of the significant components of deferred income tax assets and liabilities (in thousands):
 
December 31,
 
2013
 
2012
Assets:
 
 
 
Net operating loss carryforwards
$
64,811

 
$
62,257

Capital loss carryforwards
—

 
5,455

Research and development tax credits
21,401

 
19,627

Other tax credits
160

 
249

Intangible assets
2,530

 
1,332

Deferred revenue
4,143

 
3,915

Accrued expenses
10,519

 
7,871

Inventory
6,498

 
5,750

Stock-based compensation
9,263

 
7,881

Other temporary differences
3,642

 
4,863

 
122,967

 
119,200

Valuation allowance
(119,616
)
 
(116,929
)
Total deferred tax assets
3,351

 
2,271

Liabilities:
 
 
 
Purchased intangible assets
(922
)
 
(249
)
Unrealized gain on available-for-sale securities
(574
)
 
(574
)
Total deferred tax liabilities
(1,496
)
 
(823
)
Total net deferred tax assets
$
1,855

 
$
1,448

 
 
 
 
Reported as:
 
 
 
  Deferred income taxes - current
$
656

 
$
686

  Deferred income taxes - noncurrent
1,199

 
762

 
$
1,855

 
$
1,448



At December 31, 2013, the Company had cumulative net operating losses ("NOL") of $200.6 million for federal income tax purposes and $88.7 million for state income tax purposes. The federal NOL carryforwards expire at various dates from 2020 through 2033. The state NOL expires at various dates from 2014 through 2033. Of the federal NOL, $127.0 million is attributable to stock option deductions. The Company's federal NOL carryforwards for tax return purposes are $25.0 million greater than its recognized federal NOL for financial reporting purposes, primarily due to excess tax benefits (stock compensation deductions in excess of book compensation costs) not recognized for financial statement purposes until realized. The tax benefit of this loss would be recognized for financial statement purposes in the period in which the tax benefit reduces income taxes payable, which will not be recognized until the Company recognizes a reduction in taxes payable from all other NOL carryforwards. In addition, the Company has $9.3 million of deferred tax assets as of December 31, 2013 related to compensation expenses recognized for financial reporting purposes that are not deductible for tax purposes until options are exercised or shares vest. As employees will not exercise the underlying options unless the current market price exceeds the option exercise price and the Company's tax deduction for restricted shares is determined as the shares vest, the ultimate realization of the benefit related to stock options is directly associated with the price of the Company's common stock. At December 31, 2013, the Company's stock price of $3.15 was below the weighted average exercise price of the Company's stock options of $3.22.
With respect to non-U.S. NOL carryovers, the Company's United Kingdom subsidiary has a current year estimated NOL of approximately $0.8 million and a carryover of approximately $3.0 million from its acquisition of NET.
The Company also has available federal and state research and development credit carryforwards of approximately $27 million that expire at various dates from 2015 through 2033.
During 2013, $14.1 million of capital loss carryover resulting from the Company's sale of its Zynetix subsidiary on November 26, 2008 expired. The capital loss was only available to offset capital gains. Because it was not more likely than not that the Company would realize a benefit prior to the expiration of the capital loss carryforward, a full valuation allowance had been established against the $5.5 million tax benefit associated with this capital loss.
During 2013 and 2012, the Company performed an analysis to determine if, based on all available evidence, it considered it more likely than not that some portion or all of the recorded deferred tax assets will not be realized in a future period. As a result of the Company's evaluation, the Company concluded that there was insufficient positive evidence to overcome the more objective negative evidence related to its cumulative losses and other factors. Accordingly, the Company has maintained a valuation allowance against its domestic deferred tax asset amounting to $119.6 million at December 31, 2013 and $116.9 million at December 31, 2012.

A reconciliation of the Company's unrecognized tax benefits is as follows (in thousands):
 
2013
 
2012
 
2011
Unrecognized tax benefits at January 1
$
8,847

 
$
10,004

 
$
9,990

Increases related to current year tax positions
14

 
14

 
14

Decreases related to prior period tax positions
—

 
(1,171
)
 
—

Settlements
—

 
—

 
—

  Unrecognized tax benefits at December 31
$
8,861

 
$
8,847

 
$
10,004



The Company recorded liabilities for potential penalties and interest of $14,000 for the year ended December 31, 2013, $14,000 for the year ended December 31, 2012 and $14,000 for the year ended December 31, 2011. The Company does not expect its unrecognized tax benefits to change materially over the next 12 months. Due to the Company's valuation allowance at December 31, 2013, none of the Company's unrecognized tax benefits, if recognized, would affect the effective tax rate.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, as well as various state and foreign jurisdictions. Generally, the tax years 2008 through 2013 remain open to examination by the major taxing jurisdictions to which the Company is subject. The Company's federal NOLs generated prior to 2003 could be adjusted on examination even though the year in which the loss was generated is otherwise closed by the statute of limitations. The Company's primary state jurisdiction, Massachusetts, has open periods from 2009 through 2013.

The acquisition of NET was accounted for as a nontaxable business combination and the Company carried over the existing tax basis of the acquired assets and liabilities. Deferred taxes were recorded as part of the business combination based on the differences between the tax basis of the acquired assets or liabilities and their reported amounts for financial reporting purposes. The Company concluded that there was insufficient positive evidence to overcome the more objective negative evidence related to cumulative losses and other factors. Accordingly, the Company recorded a valuation allowance against the majority of the acquired deferred tax assets.

With respect to the acquisition of NET, during the second quarter of 2013, the Company made an election under Section 338(g) of the Internal Revenue Code to have the acquisition transaction treated as an asset acquisition (i.e., a taxable transaction). The election is not considered part of the business combination and resulted in a step-up in the acquired assets and liabilities to fair market value for tax purposes. During the third quarter of 2013, as a result of the election, the Company reversed all of the deferred taxes related to NET's assets, liabilities and net operating loss carryovers and the related valuation allowance that were recorded in the business combination. The resulting taxable gain from the election was fully offset by NET's operating loss carryovers and no taxes were paid by the Company as a result of the election.